Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study

European Journal of Cancer

Volumn 51, Issue 15, 2015, Pages 2231-2241

  Visser, Otto ^a   Ardanaz, Eva ^b,c   Botta, Laura ^d   Sant, Milena ^d   Tavilla, Andrea ^e   Minicozzi, Pamela ^d  

^a Netherlands Comprehensive Cancer Organization   (Netherlands)

^b INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Brain tumours; Cancer registry; Survival

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; EASTERN EUROPE; EMBRYONAL TUMOR; EPENDYMOMA; EUROPE; FEMALE; GLIOBLASTOMA; HUMAN; ICD-O-3; IRELAND; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 84942456279     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.07.032     Document Type: Article

References (25)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from: < http://globocan.iarc.fr >; 2013 [accessed in March 2015].
2. Steliarova-Foucher E, O'Callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European Cancer Observatory: Cancer Incidence, Mortality, Prevalence and Survival in Europe. Version 1.0 (September 2012) European Network of Cancer Registries, International Agency for Research on Cancer. Available from: < http://eco.iarc.fr >; 2015 [accessed in March 2015].
3. G. Gatta, L. Botta, S. Rossi, T. Aareleid, M. Bielska-Lasota, J. Clavel, and et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5 - a population-based study Lancet Oncol 15 2014 35 47
4. T.S. Surawicz, B.J. McCarthy, V. Kupelian, P.J. Jukich, J.M. Bruner, and F.G. Davis Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994 Neuro Oncol 1 1999 14 25
5. D.N. Louis, H. Ohgaki, O.D. Wiestler, and W.K. Cavenee WHO classification of tumours of the central nervous system 4th ed. 2007 IARC Press Lyon
6. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Hinsdale, IL: Central Brain Tumor Registry of the United States (CBTRUS). Available from: < www.cbtrus.org >; 2010 [accessed in March 2015].
7. M. Sant, G. van der Sanden, and R. Capocaccia Survival rates for primary malignant brain tumours in Europe. EUROCARE Working Group Eur J Cancer 34 1998 2241 2247
8. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, and et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 10 352 2005 987 999
9. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, R.C. Janzer, and et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
10. A. Fritz, C. Percy, A. Jack, K. Shanmugaratnam, L. Sobin, D.M. Parkin, and et al. International classification of diseases for oncology 3rd ed. 2000 World Health Organization Geneva
11. Rossi S, Baili P, Caldora M, Carrani E, Minicozzi P, Pierannunzio D, et al. The EUROCARE-5 study on cancer survival in Europe: database, quality checks and methods of statistical analysis. Eur J Cancer 2015;51:2104-19.
12. H. Brenner, and O. Gefeller Deriving more up-to-date estimates of long term patient survival J Clin Epidemiol 50 1997 211 216
13. H. Brenner, and T. Hakulinen Up-to-date long term survival curves of patients with cancer by period analysis J Clin Oncol 20 2002 826 832
14. D.M. Parkin, and T. Hakulinen Cancer registration: principles and methods. Analysis of survival IARC Sci Publ 1991 159 176
15. I. Corazziari, M. Quinn, and R. Capocaccia Standard cancer patient population for age standardizing survival ratios Eur J Cancer 40 2004 4170 4176
16. Ederer F, Heise H. Instructions to IBM 650 Programmers in processing survival computations. Methodological note No. 10. End Results Evaluation Section. Bethesda, MD: National Cancer Institute; 1959.
17. N. Howlader, A.M. Noone, M. Krapcho, J. Garshell, D. Miller, S.F. Altekruse, and et al. SEER Cancer Statistics Review, 1975-2011 2014 National Cancer Institute Bethesda, MD Available from: http://seer.cancer.gov/csr/1975-2011/ [accessed in March 2015]
18. V.K. Ho, J.C. Reijneveld, R.H. Enting, H.P. Bienfait, P. Robe, B.G. Baumert, and et al. Changing incidence and improved survival of gliomas Eur J Cancer 50 2014 2309 2318
19. FDA approval for temozolomide. Bethesda, MD: National Cancer Institute; 2013. Available from: http://www.cancer.gov/cancertopics/druginfo/fda-temozolomide [accessed in March 2015].
20. European public assessment report (EPAR) for Temodal. European Medicines Agency. Available from: < http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000229/human-med-001085.jsp&mid=WC0b01ac058001d124 >; 2009 [accessed in March 2015].
21. R. Fuentes-Raspall, M. Puig-Vives, S. Guerra-Prio, F. Perez-Bueno, and R. Marcos-Gragera Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-era Cancer Epidemiol 38 2014 244 247
22. D. Robinson, R. Sankila, T. Hakulinen, and H. Møller Interpreting international comparisons of cancer survival: the effect of incomplete registration and the presence of death certificate only cases on survival estimates Eur J Cancer 45 2007 909 913
23. R. De Angelis, M. Sant, M.P. Coleman, S. Francisci, P. Baili, D. Pierannunzio, and et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study Lancet Oncol 15 2014 23 34
24. K. Innos, A. Baburin, and T. Aareleid Cancer patient survival in Estonia 1995-2009: time trends and data quality Cancer Epidemiol 38 2014 253 258
25. Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, et al. Survival for all cancer patients diagnosed between 1999 and 2007 in Europe: results of EUROCARE-5, a population-based study. Eur J Cancer 2015;51:2120-29.